RCUS Arcus Biosciences, Inc. Stock Quote

RCUS [NYSE]

Index	-	P/E	-	EPS (ttm)	-0.01	Insider Own	1.10%	Shs Outstand	71.19M	Perf Week	3.65%
Market Cap	1.71B	Forward P/E	-	EPS next Y	-4.54	Insider Trans	-4.81%	Shs Float	48.15M	Perf Month	34.18%
Income	57.40M	PEG	-	EPS next Q	-0.94	Inst Own	68.80%	Short Float	14.62%	Perf Quarter	-33.10%
Sales	391.40M	P/S	4.37	EPS this Y	131.90%	Inst Trans	-0.41%	Short Ratio	4.88	Perf Half Y	-44.37%
Book/sh	11.19	P/B	2.18	EPS next Y	-14.00%	ROA	4.70%	Target Price	57.20	Perf Year	-15.91%
Cash/sh	17.31	P/C	1.41	EPS next 5Y	-	ROE	8.20%	52W Range	16.74 - 49.10	Perf YTD	-39.66%
Dividend	-	P/FCF	3.90	EPS past 5Y	29.60%	ROI	6.20%	52W High	-50.26%	Beta	0.75
Dividend %	-	Quick Ratio	7.80	Sales past 5Y	-	Gross Margin	-	52W Low	45.88%	ATR	1.61
Employees	366	Current Ratio	7.80	Sales Q/Q	89.50%	Oper. Margin	15.30%	RSI (14)	56.80	Volatility	7.09% 7.51%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	11.70%	Profit Margin	14.70%	Rel Volume	0.36	Prev Close	25.31
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 09 AMC	Payout	0.00%	Avg Volume	1.44M	Price	24.42
Recom	1.70	SMA20	10.26%	SMA50	6.85%	SMA200	-25.20%	Volume	518,185	Change	-3.52%

Oct-15-21

Resumed

BTIG Research

Buy

$57

Nov-24-20

Initiated

Berenberg

Buy

$50

Nov-23-20

Initiated

Evercore ISI

Outperform

Apr-03-20

Initiated

Cantor Fitzgerald

Overweight

$21

Mar-04-20

Initiated

Barclays

Overweight

$24

Nov-12-19

Initiated

SunTrust

Buy

$20

Sep-27-19

Initiated

Mizuho

Buy

$22

May-24-19

Resumed

Citigroup

Buy

$25

Oct-09-18

Initiated

Wedbush

Outperform

$22

Apr-09-18

Initiated

Leerink Partners

Outperform

$21

Apr-09-18

Initiated

Goldman

Neutral

$18

Apr-09-18

Initiated

Citigroup

Buy

$18

Jun-25-22 10:44AM	Arcus Biosciences, Inc.'s (NYSE:RCUS) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? Simply Wall St.
Jun-24-22 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Jun-09-22 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
May-31-22 04:05PM	Arcus Biosciences to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference Business Wire
May-24-22 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire -5.92%
May-12-22 09:57AM	Roche (RHHBY) Phase III NSCLC Study Disappoints, Stock Down Zacks +6.67%
May-11-22 04:09PM	Biotech Stocks Hammered On Roche's Unexpected Failure In Lung Cancer Investor's Business Daily -28.24%
09:49AM	Arcus Biosciences (NYSE:RCUS) shareholders have earned a 34% CAGR over the last three years Simply Wall St.
May-10-22 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire +11.67%
May-09-22 05:55PM	Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates Zacks
04:03PM	Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study Business Wire
Apr-26-22 04:30PM	Arcus Biosciences to Report First Quarter 2022 Financial Results and Pipeline Update Business Wire -6.88%
04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Apr-20-22 06:45AM	4 Undervalued Biotech Stocks to Add to Your Buy List InvestorPlace
Apr-11-22 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire -6.97%
Apr-05-22 02:55PM	Trending Stocks on Tuesday: Top 10 Gainers Insider Monkey +8.14%
07:26AM	Arcus shares jump 13% after announcing plans to join S&P SmallCap 600 MarketWatch
Apr-04-22 06:45PM	Arcus Biosciences Set to Join S&P SmallCap 600 PR Newswire +9.07%
Mar-24-22 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire +5.28%
Mar-09-22 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Mar-08-22 04:30PM	Arcus Biosciences Presents Data from its Pipeline at Multiple Scientific Conferences Business Wire
Feb-24-22 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire +18.59%
Feb-23-22 06:45PM	Arcus Biosciences, Inc. (RCUS) Q4 Earnings and Revenues Surpass Estimates Zacks
04:05PM	Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update Business Wire
Feb-15-22 04:10PM	Arcus Biosciences to Participate in the Upcoming Investor Conferences Business Wire
Feb-09-22 05:04PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire +6.44%
Feb-07-22 01:12PM	We're Hopeful That Arcus Biosciences (NYSE:RCUS) Will Use Its Cash Wisely Simply Wall St.
Feb-01-22 05:08PM	Patent Settlement Slams Gileads Earnings. Theres More Bad News. Barrons.com
Jan-28-22 05:38PM	White Pine Investment CO Buys Amazon.com Inc, BTC iShares Morningstar Large-Cap Growth ETF, ... GuruFocus.com
Jan-25-22 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Jan-14-22 11:42AM	Hedge Funds Are Selling Arcus Biosciences, Inc. (RCUS) Insider Monkey
Jan-11-22 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Jan-10-22 08:00AM	Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones Business Wire
Dec-24-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Dec-22-21 07:15PM	Arcus Biosciences Inc (RCUS) COO Jennifer Jarrett Sold $1.4 million of Shares GuruFocus.com
Dec-21-21 04:35PM	Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-Stage Programs and New Research Collaboration Business Wire
04:35PM	Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-stage Programs and New Research Collaboration Business Wire
12:15AM	Arcus Biosciences Inc (RCUS) COO Jennifer Jarrett Sold $508,641 of Shares GuruFocus.com
Dec-14-21 04:05PM	Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer GlobeNewswire
Dec-09-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
08:20AM	Why Arcus Biosciences Stock Vaulted Higher in November Motley Fool
Nov-30-21 01:00AM	Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences Anti-TIGIT Program in Japan and Certain Territories in Asia Business Wire
Nov-26-21 08:46AM	Gilead Sciences (GILD) Stock Gains 20% YTD: What Lies Ahead? Zacks
Nov-24-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Nov-22-21 04:10PM	Arcus Biosciences to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference Business Wire
Nov-21-21 08:21PM	2 Strong Buy Stocks Showing Monster Growth TipRanks
Nov-19-21 09:43AM	Gilead (GILD) Exercises Options to Three Arcus Programs Zacks +9.21%
Nov-18-21 04:18PM	Arcus Stock Rockets To Record As Gilead Unexpectedly Opts Into Cancer Drugs Investor's Business Daily +17.96%
09:53AM	Why Are Arcus Biosciences Shares Trading Higher Today? Benzinga
08:44AM	Why Arcus Biosciences Stock Is On Fire Today Motley Fool
07:38AM	Arcus Biosciences shares rocket premarket after Gilead exercises options for 3 cancer programs for $725 million MarketWatch
07:00AM	Gilead Exercises Options to Three Arcus Biosciences Clinical-Stage Programs and Adds Research Collaboration Business Wire
Nov-15-21 06:01AM	10 Best Biotech Stocks to Buy According to Mark Lamperts Biotechnology Value Fund Insider Monkey
Nov-09-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire +11.97%
Nov-08-21 06:25PM	Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:10PM	Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update on our anti-TIGIT Domvanalimab Business Wire
01:15PM	Are Investors Undervaluing Arcus Biosciences, Inc. (NYSE:RCUS) By 45%? Simply Wall St.
Nov-02-21 04:10PM	Arcus Biosciences to Report Third Quarter 2021 Financial Results & Recent Corporate Highlights Business Wire
Oct-28-21 03:05PM	Earnings Preview: Arcus Biosciences, Inc. (RCUS) Q3 Earnings Expected to Decline Zacks
Oct-26-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Oct-25-21 10:01AM	Hedge Funds Are Cashing Out Of Arcus Biosciences, Inc. (RCUS) Insider Monkey
Oct-11-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Sep-27-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Sep-09-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Sep-01-21 04:10PM	Arcus Biosciences to Participate at Upcoming Investor Conferences Business Wire +8.16%
Aug-24-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Aug-10-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Aug-08-21 03:54AM	These Analysts Just Made A Substantial Downgrade To Their Arcus Biosciences, Inc. (NYSE:RCUS) EPS Forecasts Simply Wall St.
Aug-05-21 08:45PM	Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:10PM	Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights Business Wire
Jul-29-21 04:10PM	Arcus Biosciences to Report Second Quarter 2021 Financial Results & Recent Corporate Highlights Business Wire
03:05PM	Will Arcus Biosciences, Inc. (RCUS) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-26-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Jul-20-21 04:01PM	Arcus Surges As Executive Transfer Could Signal Deeper Gilead Partnership Investor's Business Daily +8.03%
Jul-13-21 09:07AM	Is Arcus Biosciences, Inc. (RCUS) A Good Stock To Buy? Insider Monkey
Jul-12-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Jul-02-21 05:54AM	Can You Imagine How Jubilant Arcus Biosciences' (NYSE:RCUS) Shareholders Feel About Its 113% Share Price Gain? Simply Wall St.
Jun-25-21 08:45AM	Arcus Biosciences, Inc. (RCUS) Stock Jumps 15.5%: Will It Continue to Soar? Zacks +6.70%
06:29AM	Why Arcus Biosciences' Big Reveal Wasn't Very Exciting Motley Fool
Jun-24-21 04:16PM	Arcus Biosciences Rockets, But Vague Update In Cancer Study Divides Analysts Investor's Business Daily +15.47%
04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
11:54AM	Here's Why Arcus Biosciences Stock Is Rising Today Motley Fool
09:42AM	Arcus stock jumps 19% after announcing it will move forward with trial for lung-cancer treatment MarketWatch
Jun-23-21 04:10PM	Anti-TIGIT Domvanalimab-Based Combinations Showed Encouraging Clinical Activity in People with Metastatic, PDL1-High Non-Small Cell Lung Cancer at First Interim Analysis of Arcus Biosciences Randomized Phase 2 ARC-7 Study Business Wire
Jun-09-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
May-25-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
May-19-21 05:05PM	Arcus Biosciences Presents Early Data from ARC-6, a Phase 1b/2 Study Evaluating Etrumadenant-Based Combinations in Metastatic Castrate-Resistant Prostate Cancer at the 2021 ASCO Annual Meeting Business Wire -5.19%
May-11-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
May-05-21 08:15PM	Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates Zacks -5.38%
04:10PM	Arcus Biosciences Reports First Quarter 2021 Financial Results and Provides Operational Highlights Business Wire
May-01-21 07:31PM	Top Insider Buys Highlight for the Week of April 30 GuruFocus.com
Apr-26-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Apr-10-21 08:33AM	Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2 Program at the AACR 2021 Annual Meeting Business Wire
Apr-09-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Apr-03-21 04:10AM	Independent Director Kathryn Falberg Just Bought 12% More Shares In Arcus Biosciences, Inc. (NYSE:RCUS) Simply Wall St.
Mar-24-21 04:15PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire -7.08%
Mar-12-21 12:24PM	Arcus Biosciences, Inc. (RCUS) Stock Jumps 9.5%: Will It Continue to Soar? Zacks -6.56%
Mar-09-21 04:10PM	Arcus Biosciences Announces New Employment Inducement Grants Business Wire
Mar-04-21 12:13AM	Industry Analysts Just Upgraded Their Arcus Biosciences, Inc. (NYSE:RCUS) Revenue Forecasts By 10% Simply Wall St.
Feb-28-21 02:09AM	Analysts Are Upgrading Arcus Biosciences, Inc. (NYSE:RCUS) After Its Latest Results Simply Wall St.

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for monotherapy. The company also develops Domvanalimab, an anti-TIGIT monoclonal antibody, which is in Phase 2 development for the treatment of first-line metastatic non-small cell lung cancer in combination with Zimberelimab; Quemliclustat, a small-molecule CD73 inhibitor is in a Phase 1/1b study for the treatment of first-line metastatic pancreatic cancer; and AB521, an oral and small molecule HIF-2a inhibitor that is in Phase 1 study for the treatment of patients with von Hippel- Lindau disease. It has a clinical development collaboration agreement with Strata Oncology, Inc. to evaluate Zimberelimab; a collaboration with AstraZeneca, BVF Partners L.P to evaluate domvanalimab, its investigational anti-TIGIT antibody, in combination with Imfinzi (durvalumab) in a registrational Phase 3 clinical trial in patients with unresectable Stage III non-small cell lung cancer; and license agreements with Taiho Pharmaceutical Co., Ltd, Abmuno Therapeutics LLC, and WuXi Biologics to develop anti-CD39 antibody for the treatment of cancer. The company was incorporated in 2015 and is headquartered in Hayward, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tang Carolyn C.	General Counsel	Jun 17	Sale	22.12	1,522	33,665	23,909	Jun 21 04:23 PM
Jaen Juan C.	President	Jun 17	Sale	22.12	2,537	56,116	210,037	Jun 21 04:18 PM
Jarrett Jennifer	Chief Operating Officer	Jun 17	Sale	22.12	6,614	146,294	118,619	Jun 21 04:19 PM
ROSEN TERRY J	Chief Executive Officer	Jun 17	Sale	22.12	4,613	102,034	227,716	Jun 21 04:21 PM
ROSEN TERRY J	Chief Executive Officer	Jun 16	Sale	20.72	4,241	87,874	232,329	Jun 21 04:21 PM
Jarrett Jennifer	Chief Operating Officer	Jun 16	Sale	20.72	6,081	125,998	125,233	Jun 21 04:19 PM
Jaen Juan C.	President	Jun 16	Sale	20.72	2,333	48,340	212,574	Jun 21 04:18 PM
Tang Carolyn C.	General Counsel	Jun 16	Sale	20.72	1,400	29,008	25,431	Jun 21 04:23 PM
Jarrett Jennifer	Chief Operating Officer	Mar 16	Sale	31.62	9,617	304,090	105,978	Mar 18 04:43 PM
Jarrett Jennifer	Chief Operating Officer	Dec 20	Sale	41.48	34,822	1,444,369	90,595	Dec 22 05:03 PM
ROSEN TERRY J	Chief Executive Officer	Dec 17	Sale	40.36	2,943	118,771	211,570	Dec 20 04:16 PM
Jarrett Jennifer	Chief Operating Officer	Dec 17	Sale	40.36	7,118	287,261	125,417	Dec 20 04:17 PM
Jaen Juan C.	President	Dec 17	Sale	40.36	1,108	44,715	201,157	Dec 20 04:19 PM
Goeltz II Robert C.	Chief Financial Officer	Dec 17	Sale	40.36	621	25,061	7,019	Dec 20 04:22 PM
Tang Carolyn C.	General Counsel	Dec 17	Sale	40.36	622	25,102	17,564	Dec 20 04:26 PM
Tang Carolyn C.	General Counsel	Dec 16	Sale	39.82	487	19,394	18,186	Dec 20 04:26 PM
Goeltz II Robert C.	Chief Financial Officer	Dec 16	Sale	39.83	485	19,315	7,640	Dec 20 04:22 PM
Jaen Juan C.	President	Dec 16	Sale	39.82	865	34,448	202,265	Dec 20 04:19 PM
Jarrett Jennifer	Chief Operating Officer	Dec 16	Sale	39.82	5,560	221,423	132,535	Dec 20 04:17 PM
ROSEN TERRY J	Chief Executive Officer	Dec 16	Sale	39.82	2,299	91,556	214,513	Dec 20 04:16 PM
Jarrett Jennifer	Chief Operating Officer	Sep 21	Sale	35.64	16,866	601,088	112,843	Sep 22 04:32 PM
Jarrett Jennifer	Chief Operating Officer	Sep 20	Sale	35.18	30,634	1,077,826	129,709	Sep 22 04:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience